Author:
Abate Biruk Beletew,Tilahun Befkad Derese,Yayeh Berihun Mulu
Abstract
Abstract
Background
The COVID-19 vaccination is essential for reducing disease burden on a worldwide scale. The success of this strategy will largely depend on how well vaccines are received. Previous reviews had produced contradictory results, and there had been no umbrella review. Therefore, the objective of this umbrella review was to combine the contradictory data regarding the COVID-19 vaccination’s global acceptance rate and its contributing factors.
Methods
Using PRISMA guideline, PubMed, Embase, Scopus, Web of Sciences, Cochrane Database of Systematic Reviews, Scopus and Google Scholar which reported COVID-19 vaccine acceptance and/or its determinants were searched. The quality of the included studies was assessed using Assessment of Multiple Systematic Reviews (AMSTAR). A weighted inverse variance random-effects model was applied to find the pooled estimates. The subgroup analysis, heterogeneity, publication bias and sensitivity analysis were also assessed.
Result
Twenty-two SRM with 10,433,306 study participants were included. The pooled COVID-19 vaccine acceptance rate globally is found to be 60.23 (95% CI: 58.27, 62.18). In low-income countries, the pooled level of COVID-19 vaccine acceptance was found to be 54.07(50.31, 57.83) while this magnitude is 64.32 (62.24,66.40) among studies across the globe. Higher level of education (AOR =1.96; 95% CI:1.20, 2.73), good level of knowledge (2.20; 95% CI:1.36, 3.03), favourable attitude (AOR =4.50; 95% CI:2.89, 6.12), previous history of COVID-19 infection (AOR =3.41; 95% CI:1.77, 5.06), male sex (AOR =1.62; 95% CI:1.47, 1.77), and chronic disease (AOR =1.54; 95% CI:1.18, 1.90) were predictors of COVID-19 vaccine acceptance.
Conclusion
The pooled level of COVID-19 vaccine acceptance highly varied and found to be unacceptably low particularly in low-income countries. Higher level of education, good level of knowledge, favourable attitude, previous history of COVID-19, male sex, and chronic disease were factors of COVID-19 vaccine acceptance rate. A collaborative effort of stakeholders such as policymakers, and vaccine campaign program planners is needed to improve the acceptance rate of COVID-19 vaccine.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference75 articles.
1. Chen J, Lu H. New challenges to fighting COVID-19: virus variants, potential vaccines, and development of antivirals. Biosci Trends. 2021;15(2):126–8.
2. Addisu A, Getahun T, Deti M, Negesse Y, Mekonnen B. Association of acute respiratory infections with indoor air pollution from biomass fuel exposure among under-five children in Jimma town, southwestern Ethiopia. J Environ Public Health. 2021;2021:7112548.
3. Eneh SC, Okonji OC, Chiburoma AG, Francisca Ogochukwu O, Tuwleh L, Gideon I, et al. Marburg virus disease amid COVID-19 in West Africa: an emerging and re-emerging zoonotic epidemic threat, future implications and way forward. London, England: SAGE Publications Sage UK; 2023. p. 20499361231168520.
4. Poukka E, Nohynek H, Goebeler S, Leino T, Baum U. Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022–march 2023. medRxiv. 2023;2023 https://doi.org/10.1101/2023.03.02.23286561.
5. Cooper S, van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines. 2021;20(8):921–33.